The article on “UK consensus group calls for biomarker testing at point of diagnosist” has been published in the Cancer World online magazine (Sep, 2022).
In the article, Mark Lawler (CDDF, UK), comments on the consensus statement, saying, “I welcome the conclusions of this consensus group, which offers a pragmatic approach by focusing on what can practically be achieved in real-world settings, as opposed to aspirational targets only achievable in clinical trials and research studies.”
Read the full text here: UK consensus group calls for biomarker testing at point of diagnosis